NewsRx

Search our medical news database

Vaccine Research

Cancer vaccines emerge as novel therapies are developed and tested

Published in Gene Therapy Weekly, September 7th, 2006

Researchers at The University of Texas M. D. Anderson Cancer Center are testing an experimental vaccine that homes to a protein studding the surface of glioblastoma cancer cells.

It tricks the body into thinking this protein is foreign and infectious, which alerts killer immune cells. The same kind of strategy is producing promising results in clinical trials at M. D. Anderson of vaccines for advanced myeloid leukemia as well as other forms of leukemia, aggressive lymphoma and melanoma.

Because of the preliminary nature of therapeutic cancer vaccines - none has yet been approved for use anywhere in the world - researchers can only describe their...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook